Vaccine Programs:


Our vaccine pipeline: excellent clinical safety profile and robust immunogenicity.

Starting from only viral sequence data (no physical virus), Codagenix can routinely design, construct, and grow multiple live-attenuated vaccine candidates ready for animal safety and efficacy testing in less than one month, and faster if needed as new outbreak strains are identified. Our vaccines are distinguished by their excellent safety profile and robust immunogenicity. We seek to upend the current approach to making live-attenuated vaccines, tackling challenging problems in vaccine science, such as an RSV vaccine for the elderly population, a tetravalent dengue vaccine, and many others.